ClavystBio
NSG BioLabs raises US$14.5mil from Celadon Partners and Temasek's ClavystBio
NSG BioLabs, has announced partnerships with Enterprise Singapore and Merck to bolster Singapore's biotech landscape.
Engine Biosciences secures US$27m for precision oncology and biomarkers
Engine Biosciences has announced the completion of a US$27 mil Series A extension.